Teva Parenteral Medicines, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA, is a leader in the development and marketing of generic injectables. Using internal Research and Development capabilities, together with operational flexibility and manufacturing and regulatory expertise, Teva is able to take a wide variety of products from the laboratory to the market.
Teva Pharmaceuticals USA is a leading generic pharmaceutical company, marketing products from a wide range of therapeutic areas including analgesic, anti-infective, cardiovascular, oncology, CNS, dermatological and anti-inflammatory. Dosage forms include extended and immediate release tablets and capsules, injectables, creams, ointments, solutions and suspensions. Teva USA has an aggressive Research and Development effort and one of the best overall ANDA approval records in the industry.
Our mission is to play a leading role in the transformation of the U.S. healthcare system through its preeminence in the development, manufacture and marketing of generic pharmaceuticals.